Future gazing in the management of multiply drug-resistant Gram-positive infection

被引：7
|
作者：
Wilcox, Mark H. [1 ,2 ]
机构：
[1] Univ Leeds, Leeds Teaching Hosp NHS Trust, Dept Microbiol, Leeds, W Yorkshire, England
[2] Univ Leeds, Inst Mol & Cellular Biol, Leeds, W Yorkshire, England
来源：
JOURNAL OF INFECTION | 2009年 / 59卷
关键词：
Antimicrobial selection; Multidrug resistance; Gram-positive bacteria; Guidelines; Linezolid; MRSA; STAPHYLOCOCCUS-AUREUS; DOUBLE-BLIND; NOSOCOMIAL INFECTION; RISK-FACTOR; MUPIROCIN; SURVEILLANCE; SUSCEPTIBILITY; PROPHYLAXIS; VANCOMYCIN; EXPOSURE;
D O I：
10.1016/S0163-4453(09)60010-4
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Gram-positive bacteria have evolved to become predominant health care associated pathogens. To meet this challenge, novel approaches to the development, prescribing, and control of antibiotics will be needed. Additional infection control methods must also be explored. This review discusses the challenges posed in particular by methicillin-resistant staphylococci and potential ways forward. (c) 2009 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：S75 / S80
页数：6
相关论文
共 50 条
  • [1] New treatments for multiply drug-resistant Gram-positive bacteria
    Moellering, Robert C., Jr.
    [J]. JOURNAL OF INFECTION, 2009, 59 : S1 - S3
  • [2] Management of drug-resistant gram-positive infections
    Grayson, L.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 73 : 32 - 32
  • [3] Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria
    Eliopoulos, George M.
    [J]. JOURNAL OF INFECTION, 2009, 59 : S17 - S24
  • [4] The management of infections due to drug-resistant gram-positive bacteria
    R. C. Moellering
    [J]. European Journal of Clinical Microbiology and Infectious Diseases, 2005, 24 : 777 - 779
  • [5] The management of infections due to drug-resistant gram-positive bacteria
    Moellering, RC
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2005, 24 (12) : 777 - 779
  • [6] Multiply resistant Gram-positive bacteria
    不详
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 31 - 36
  • [7] Activity of siderophores against drug-resistant Gram-positive and Gram-negative bacteria
    Gokarn, Karuna
    Pal, Ramprasad B.
    [J]. INFECTION AND DRUG RESISTANCE, 2018, 11 : 61 - 75
  • [8] New agents to treat drug-resistant Gram-positive antimicrobial infections as well as anthrax and drug-resistant tuberculosis
    Kabir, M. Shahjahan
    Ara, Shamim
    Polanowski, Rebecca L.
    Engelbrecht, Kathleen
    Stemper, Mary E.
    Krueger, Sarah M.
    Rott, Marc A.
    Schwan, William R.
    Monte, Aaron P.
    Cook, James M.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [9] Linezolid: Its role in the treatment of gram-positive, drug-resistant bacterial infections
    Ament, PW
    Jamshed, N
    Horne, JP
    [J]. AMERICAN FAMILY PHYSICIAN, 2002, 65 (04) : 663 - 670
  • [10] Health economic issues in the treatment of drug-resistant serious Gram-positive infections
    Nathwani, Dilip
    [J]. JOURNAL OF INFECTION, 2009, 59 : S40 - S50
12345